Lilly Xu

541 total citations
8 papers, 425 citations indexed

About

Lilly Xu is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Lilly Xu has authored 8 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Lilly Xu's work include Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Lilly Xu is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Lilly Xu collaborates with scholars based in United States, Russia and China. Lilly Xu's co-authors include Albert P. Li, Donald L. Kaminski, Gary L. Skiles, Magang Shou, Mary F. Ruh, Margaret Reith, Stephen D. Hall, John Gorski, Yang Xu and Kari M. Morrissey and has published in prestigious journals such as Nucleic Acids Research, Biochemical Pharmacology and Drug Metabolism and Disposition.

In The Last Decade

Lilly Xu

8 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lilly Xu United States	7	236	148	87	77	49	8	425
David E. Harbourt United States	7	203 0.9×	113 0.8×	162 1.9×	82 1.1×	41 0.8×	12	501
Maroeska Oudshoorn Netherlands	7	227 1.0×	154 1.0×	150 1.7×	65 0.8×	32 0.7×	10	535
I. Gardner United Kingdom	10	195 0.8×	103 0.7×	133 1.5×	50 0.6×	17 0.3×	17	510
Cornelia M. Smith United States	6	258 1.1×	126 0.9×	110 1.3×	39 0.5×	64 1.3×	7	574
B. Kevin Park United Kingdom	13	157 0.7×	93 0.6×	151 1.7×	61 0.8×	25 0.5×	15	485
Michael E. Fitzsimmons United States	10	180 0.8×	151 1.0×	125 1.4×	120 1.6×	16 0.3×	16	466
Stanley Roberts United States	13	121 0.5×	127 0.9×	202 2.3×	68 0.9×	68 1.4×	19	595
Dominic Surry United Kingdom	16	269 1.1×	354 2.4×	146 1.7×	68 0.9×	31 0.6×	19	639
Darryl Gilbert United States	8	359 1.5×	239 1.6×	118 1.4×	45 0.6×	28 0.6×	8	626
Émilie Jigorel France	6	250 1.1×	410 2.8×	115 1.3×	46 0.6×	25 0.5×	6	593

Countries citing papers authored by Lilly Xu

Since Specialization

Citations

This map shows the geographic impact of Lilly Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilly Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilly Xu more than expected).

Fields of papers citing papers by Lilly Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lilly Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilly Xu. The network helps show where Lilly Xu may publish in the future.

Co-authorship network of co-authors of Lilly Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lilly Xu. A scholar is included among the top collaborators of Lilly Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilly Xu. Lilly Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Xu, Lilly, et al.. (2024). Comparing the effects of three neonicotinoids on embryogenesis of the South African clawed frog Xenopus laevis. Current Research in Toxicology. 6. 100169–100169. 3 indexed citations

2.

Chen, Qingyu, Alexis Allot, Robert Leaman, et al.. (2022). LitCovid in 2022: an information resource for the COVID-19 literature. Nucleic Acids Research. 51(D1). D1512–D1518. 12 indexed citations

3.

Zhu, Yong, Shaoqiu Chen, Lilly Xu, et al.. (2021). Comprehensive Analysis of a tRNA-Derived Small RNA in Colorectal Cancer. Frontiers in Oncology. 11. 701440–701440. 13 indexed citations

4.

Xu, Lilly, et al.. (2009). Prediction of Human Drug-Drug Interactions from Time-Dependent Inactivation of CYP3A4 in Primary Hepatocytes Using a Population-Based Simulator. Drug Metabolism and Disposition. 37(12). 2330–2339. 67 indexed citations

5.

Shou, Magang, et al.. (2008). Modeling, Prediction, and in Vitro in Vivo Correlation of CYP3A4 Induction. Drug Metabolism and Disposition. 36(11). 2355–2370. 102 indexed citations

6.

Xu, Lilly, Albert P. Li, Donald L. Kaminski, & Mary F. Ruh. (2000). 2,3,7,8 Tetrachlorodibenzo-p-dioxin induction of cytochrome P4501A in cultured rat and human hepatocytes. Chemico-Biological Interactions. 124(3). 173–189. 77 indexed citations

7.

Xu, Lilly, Thomas S. Ruh, & Mary F. Ruh. (1997). Effect of the histone deacetylase inhibitor trichostatin a on the responsiveness of rat hepatocytes to dioxin. Biochemical Pharmacology. 53(7). 951–957. 20 indexed citations

8.

Li, Albert P., Margaret Reith, John Gorski, et al.. (1997). Primary human hepatocytes as a tool for the evaluation of structure—activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin. Chemico-Biological Interactions. 107(1-2). 17–30. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact